TandemLife is now a part of LivaNova, Learn More Here.
American College of Cardiology’s 68th Annual March 16-18, 2019 | Booth #653 Ernest N. Morial Convention Center | 900 Convention Center Blvd, New Orleans, LA 70130 TandemLife is the only MCS platform to offer a “Time to Decide™” Strategy, enabling simple, accessible, temporary ECLS support in minutes. Stop by Booth #653 to learn more about how
London, April 4, 2018 – LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, today announced it closed its acquisition of TandemLife. Previously, on Feb. 14, LivaNova announced its intent to acquire TandemLife, a privately held company focused on advanced cardiopulmonary temporary support solutions. “The acquisition of TandemLife allows us to complement
The priming tray was designed to provide hospitals with a simple, repeatable priming process that can be implemented quickly wherever cardiopulmonary support is needed. Contact us here to learn more.
Check out Robert Burton’s story of survival and journey to a kidney transplant. Click HERE.
In his own words – TandemHeart – Dr. Christoper Overgaard *Device duration varies by country. Indications for Use – USA TandemHeart Pump: The TandemHeart System is intended for extracorporeal circulatory support using an extracorporeal bypass circuit. Intended duration of use is for periods appropriate to cardiopulmonary bypass, up to six hours. It is also intended
-Courtesy of Peter Munk Cardiac Centre UHN- TandemHeart System offers new option to treat clinically-challenging cardiac condition A multi-disciplinary medical team of interventional and structural cardiologists at the Peter Munk Cardiac Centre, University Health Network, has successfully completed a Canadian first — the implant of a TandemHeart circulatory support device designed to take over the
Our company is working to simplify life support by focusing on ease of use for clinicians and accessibility for patients. Our new TandemLife kit will be packaged in a small, sterile basin so that emergent CBP can be initiated quickly in a variety of environments. Click the link to learn how TandemLife is contributing to
In a recent interview Zain Khalpey, M.D (Director, Artificial Heart & ECMO Program, Banner University), describes the method of treating emergent cardiac failure situations with ECLS prior to full Left Ventricular unloading as the paradigm shift need to help improve results. Click the following link for the full interview: http://www.futureofpersonalhealth.com/prevention-and-treatment/expert-panel-considers-the-pressure-points-facing-cardiology. _ _ _ _
TandemLife® reveals details of the first clinical use of their new 31 Fr ProtekDuo cannula in combination with the recently released TandemLung oxygenator We’re thrilled to announce the commercial launch and first human use of our newest ProtekDuo dual lumen cannula at Cedars Sinai Heart Institute in Los Angeles. The cardiothoracic transplant team said the
TandemLife announced today, August 18th, that the Pittsburgh Technology Council has named it a Tech 50 Awards Finalist for the Innovator of the Year: Life Sciences category. “We are honored to have earned a place among some of the best life sciences companies in our region as one of the Tech50 finalists,” said John Marous,